Hours (Discovery Tools) key facts
- Developer of an AI decision-making platform intended for drug discovery and chemical synthesis.
- It has raised $11.6M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, SND Ventures Group, 5Y Capital, Linear Capital, Sinochem Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·Watch Hours (Discovery Tools): the Monday email on marks, rounds and moves
Hours (Discovery Tools) funding rounds
No funding rounds for Hours (Discovery Tools) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Hours (Discovery Tools) investors
10 investors are on record for Hours (Discovery Tools), including Suzhou Oriza Holdings Corporation, SND Ventures Group, 5Y Capital and Linear Capital.
About Hours (Discovery Tools)
Developer of an AI decision-making platform intended for drug discovery and chemical synthesis. The company offers a platform that integrates different technologies and disciplines to model complicated drug discovery and production processes, thereby enabling scientists to leverage artificial intelligence to comprehend chemical reaction mechanisms in the laboratory quickly.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2018
- Website
- hourstec.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Hours (Discovery Tools) doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.